Low Dose Naltrexone (LDN) – Immune Modulation & Inflammation Control
Low Dose Naltrexone (LDN) – Immune Modulation & Inflammation Control
Low Dose Naltrexone (LDN) works through short-term opioid receptor blockade, leading to a rebound increase in endorphin production and immune modulation. It reduces microglial activation (reduces neuroinflammatory cytokine signaling) in the central nervous system and helps regulate inflammatory pathways. Clinically, LDN is used for autoimmune conditions, chronic pain, and inflammatory disorders, supporting improved immune balance and symptom control.
Modulates immune response and reduces chronic inflammation
- Transiently blocks opioid receptors to upregulate endogenous endorphins
- Downregulates microglial activation to reduce neuroinflammation
- Modulates immune system activity in autoimmune conditions (calms it down)
- Reduces chronic pain and systemic inflammatory signaling
Disclaimer
Disclaimer
- Peptides and GLP-1s are lyophilized in dry powder form
- You will need to purchase bacteriostatic water for mixing/reconstituting
- A starter pack of ten syringes is often included, not guaranteed
- Alcohol swabs not included

